Form FDA 1572 – Investigator Statement
| Form FDA 1572 – Investigator Statement | |
|---|---|
| Term | Form FDA 1572 – Investigator Statement |
| Short definition | Foretinib (for-eh-TIH-pen) A substance being studied for the treatment of cancer. Foretinib blocks enzymes involved in the growth and spread of tumor cells. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Form FDA 1572 – Investigator Statement - (pronounced) (. . . STAYT-ment . . . in-VES-tih-GAY-ter) A form required to be submitted by an investigator conducting a clinical trial to investigate a new drug or active substance. The investigator agrees to follow the US Food and Drug Administration (FDA) Code of Federal Regulations for the clinical study. The investigator confirms that he or she has the experience and background necessary to conduct the study and that it will be conducted in an ethically and scientifically sound manner. Also known as the 1572 form
External links
- Medical encyclopedia article on Form FDA 1572 – Investigator Statement
- Wikipedia's article - Form FDA 1572 – Investigator Statement
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski